Drug: Leronlimab
Company: CytoDyn Inc.
Website: https://www.cytodyn.com/

Clinical Trial Enrollment:

 Mild to Moderate: https://www.cytodyn.com/clinical-trial-enrollment
 Severe or Critical: https://www.cytodyn.com/clinical-trial-enroll...r-critical
 FDA Emergency IND Hotline: 855-543-3784 (Have doctor file with the FDA)


CytoDyn CEO:

Nader Pourhassan, PhD
Director, President & CEO

CytoDyn Inc. (www.cytodyn.com)
1111 Main Street, Suite 660
Vancouver, Washington 98660

(360) 980-8524 Ext. 1
(360) 980-8549 - Fax
(503) 348-4173-Cell

Email: npourhassan@cytodyn.com